Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.24.2
Accrued Expenses
6 Months Ended
Jun. 30, 2024
Payables and Accruals [Abstract]  
Accrued Expenses

8. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following as of June 30, 2024 and December 31, 2023 (in thousands):

 

 

June 30, 2024

 

 

December 31, 2023

 

External research and preclinical development

 

$

9,117

 

 

$

8,001

 

Employee compensation and benefits

 

 

3,815

 

 

 

6,993

 

Professional fees

 

 

983

 

 

 

1,015

 

Facilities and other

 

 

642

 

 

 

137

 

Accrued expenses and other current liabilities

 

$

14,557

 

 

$

16,146